Table 3.
Comparison of clinical characteristics between BRCA mutation carriers and non-carriers who have “triple negative” cancer
| Variable | Genetic Mutation | P-value | |
|---|---|---|---|
|
| |||
| No | Yes | ||
|
| |||
| N (%) | N (%) | ||
| Age at diagnosis (years) | 0.638 | ||
| ≤ 50 | 17 (85.0) | 8 (72.7) | |
| > 50 | 3 (15.0) | 3 (27.3) | |
| BMI (Kg/m2) | 0.057 | ||
| ≤ 30 | 12 (60.0) | 2 (18.2) | |
| > 30 | 8 (40.0) | 9 (81.8) | |
| Diagnosis | 0.118 | ||
| Ductal | 20 (100.0) | 9 (81.8) | |
| Lobular | 0 (0.0) | 2 (18.2) | |
| Stage | 0.631 | ||
| 1 and 2 | 16 (80.0) | 10 (91.9) | |
| 3 | 4 (20.0) | 1 (9.09) | |
| Radiation therapy | 0.056 | ||
| No | 5 (25.0) | 7 (63.6) | |
| Yes | 15 (75.0) | 4 (36.4) | |
| Surgery | 0.273 | ||
| Lumpectomy | 12 (60.0) | 4 (36.4) | |
| Mastectomy | 8 (40.0) | 7 (63.6) | |
P-values were obtained using Fisher’s exact test.